184 related articles for article (PubMed ID: 21911383)
1. Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures.
Baliram R; Latif R; Berkowitz J; Frid S; Colaianni G; Sun L; Zaidi M; Davies TF
Proc Natl Acad Sci U S A; 2011 Sep; 108(39):16277-82. PubMed ID: 21911383
[TBL] [Abstract][Full Text] [Related]
2. TSH is a negative regulator of skeletal remodeling.
Abe E; Marians RC; Yu W; Wu XB; Ando T; Li Y; Iqbal J; Eldeiry L; Rajendren G; Blair HC; Davies TF; Zaidi M
Cell; 2003 Oct; 115(2):151-62. PubMed ID: 14567913
[TBL] [Abstract][Full Text] [Related]
3. The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis.
Ma R; Morshed S; Latif R; Zaidi M; Davies TF
Thyroid; 2011 Aug; 21(8):897-906. PubMed ID: 21745106
[TBL] [Abstract][Full Text] [Related]
4. TSH and bone loss.
Sun L; Davies TF; Blair HC; Abe E; Zaidi M
Ann N Y Acad Sci; 2006 Apr; 1068():309-18. PubMed ID: 16831931
[TBL] [Abstract][Full Text] [Related]
5. Genetic confirmation for a central role for TNFα in the direct action of thyroid stimulating hormone on the skeleton.
Sun L; Zhu LL; Lu P; Yuen T; Li J; Ma R; Baliram R; Moonga SS; Liu P; Zallone A; New MI; Davies TF; Zaidi M
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9891-6. PubMed ID: 23716650
[TBL] [Abstract][Full Text] [Related]
6. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-stimulating hormone maintains bone mass and strength by suppressing osteoclast differentiation.
Zhang W; Zhang Y; Liu Y; Wang J; Gao L; Yu C; Yan H; Zhao J; Xu J
J Biomech; 2014 Apr; 47(6):1307-14. PubMed ID: 24629929
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin, Hyperthyroidism, and Bone Mass.
Kim SM; Ryu V; Miyashita S; Korkmaz F; Lizneva D; Gera S; Latif R; Davies TF; Iqbal J; Yuen T; Zaidi M
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4809-e4821. PubMed ID: 34318885
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating hormone, thyroid hormones, and bone loss.
Zaidi M; Davies TF; Zallone A; Blair HC; Iqbal J; Moonga SS; Mechanick J; Sun L
Curr Osteoporos Rep; 2009 Jul; 7(2):47-52. PubMed ID: 19631028
[TBL] [Abstract][Full Text] [Related]
11. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
12. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
13. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.
Bennett CN; Ouyang H; Ma YL; Zeng Q; Gerin I; Sousa KM; Lane TF; Krishnan V; Hankenson KD; MacDougald OA
J Bone Miner Res; 2007 Dec; 22(12):1924-32. PubMed ID: 17708715
[TBL] [Abstract][Full Text] [Related]
14. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC
J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302
[TBL] [Abstract][Full Text] [Related]
15. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
16. Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling.
Baliram R; Sun L; Cao J; Li J; Latif R; Huber AK; Yuen T; Blair HC; Zaidi M; Davies TF
J Clin Invest; 2012 Oct; 122(10):3737-41. PubMed ID: 22996689
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling and osteoblastogenesis.
Bodine PV; Komm BS
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
[TBL] [Abstract][Full Text] [Related]
18. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
19. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G
Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165
[TBL] [Abstract][Full Text] [Related]
20. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.
Iqbal J; Sun L; Kumar TR; Blair HC; Zaidi M
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14925-30. PubMed ID: 17003115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
